输卵管癌-话题@MedSci

#输卵管癌#

19篇内容 | 895人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2193023, encodeId=3e442193023e8, content=<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌症#</a> <a href='/topic/show?id=08f236865a8' target=_blank style='color:#2F92EE;'>#卵巢癌#</a> <a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a> <a href='/topic/show?id=1a7b3e11721' target=_blank style='color:#2F92EE;'>#原发性腹膜癌#</a>, objectTitle=《2024 美国国立综合癌症网络卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南(第1版)》解读, objectType=article, longId=817012, objectId=3edb81e01260, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301012/1697154081697_4754896.jpeg, objectUrl=/article/show_article.do?id=3edb81e01260, replyNumber=0, likeNumber=10, createdTime=2024-03-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3edb81e01260, moduleTitle=《2024 美国国立综合癌症网络卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南(第1版)》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3edb81e01260)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1406972, encodeId=832914069e213, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=Clin Cancer Res：Adavosertib联合各种化疗药治疗原发铂耐药的卵巢癌、输卵管癌、腹膜癌, objectType=article, longId=293566, objectId=93972935663a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93972935663a, replyNumber=0, likeNumber=38, createdTime=2022-01-09, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93972935663a, moduleTitle=Clin Cancer Res：Adavosertib联合各种化疗药治疗原发铂耐药的卵巢癌、输卵管癌、腹膜癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93972935663a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406971, encodeId=32fd14069e1a3, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=Clin Cancer Res：Adavosertib联合化疗治疗铂耐药的卵巢癌、输卵管癌及腹膜癌的效果, objectType=article, longId=221499, objectId=28ce221499a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ce221499a5, replyNumber=0, likeNumber=36, createdTime=2021-12-05, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ce221499a5, moduleTitle=Clin Cancer Res：Adavosertib联合化疗治疗铂耐药的卵巢癌、输卵管癌及腹膜癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28ce221499a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406970, encodeId=c5da14069e0d8, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=原发性输卵管癌30例临床分析, objectType=article, longId=220979, objectId=da2a2209e9e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da2a2209e9e9, replyNumber=0, likeNumber=31, createdTime=2021-11-26, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da2a2209e9e9, moduleTitle=原发性输卵管癌30例临床分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da2a2209e9e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406969, encodeId=c7811406969ae, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=Gynecol Oncol：新诊断的卵巢癌、原发性腹膜癌和输卵管癌的静脉或腹膜内铂类化疗联合Veliparib和Bevacizumab的I期研究, objectType=article, longId=197253, objectId=32b119e253bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b119e253bc, replyNumber=0, likeNumber=29, createdTime=2020-07-10, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b119e253bc, moduleTitle=Gynecol Oncol：新诊断的卵巢癌、原发性腹膜癌和输卵管癌的静脉或腹膜内铂类化疗联合Veliparib和Bevacizumab的I期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32b119e253bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406968, encodeId=04481406968b9, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究, objectType=article, longId=197252, objectId=947b19e25234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=947b19e25234, replyNumber=0, likeNumber=40, createdTime=2020-07-10, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=947b19e25234, moduleTitle=Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=947b19e25234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406967, encodeId=4921140696edb, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=英国NICE批准将PARP抑制剂Lynparza，用于BRCA1或BRCA2突变的铂敏感型卵巢癌、输卵管癌或腹膜癌复发患者, objectType=article, longId=186454, objectId=6fbf186454dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fbf186454dd, replyNumber=0, likeNumber=44, createdTime=2020-01-19, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fbf186454dd, moduleTitle=英国NICE批准将PARP抑制剂Lynparza，用于BRCA1或BRCA2突变的铂敏感型卵巢癌、输卵管癌或腹膜癌复发患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fbf186454dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406966, encodeId=b17c14069660e, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=NICE批准PARP抑制剂Lynparza扩展用于晚期卵巢癌、输卵管癌和腹膜癌的维持治疗, objectType=article, longId=184088, objectId=1ff918408873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff918408873, replyNumber=0, likeNumber=35, createdTime=2019-12-05, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff918408873, moduleTitle=NICE批准PARP抑制剂Lynparza扩展用于晚期卵巢癌、输卵管癌和腹膜癌的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ff918408873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406965, encodeId=e7ac140696556, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2019.V2）, objectType=article, longId=180067, objectId=df2118006efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2118006efe, replyNumber=0, likeNumber=37, createdTime=2019-09-27, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2118006efe, moduleTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2118006efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406964, encodeId=30f5140696491, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=输卵管癌超声误诊阔韧带肌瘤1例, objectType=article, longId=179343, objectId=293e1e934399, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=293e1e934399, replyNumber=0, likeNumber=48, createdTime=2019-09-14, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=293e1e934399, moduleTitle=输卵管癌超声误诊阔韧带肌瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=293e1e934399)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406963, encodeId=2ff214069636a, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2019.V1）, objectType=article, longId=163060, objectId=4da1163060be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4da1163060be, replyNumber=0, likeNumber=36, createdTime=2019-03-28, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4da1163060be, moduleTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2019.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4da1163060be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406962, encodeId=e5681406962dd, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=2018 KSOG立场声明：双侧输卵管切除术降低平均风险女性卵巢癌/输卵管癌/腹膜癌风险, objectType=article, longId=150373, objectId=34251503e32a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34251503e32a, replyNumber=0, likeNumber=35, createdTime=2018-10-06, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34251503e32a, moduleTitle=2018 KSOG立场声明：双侧输卵管切除术降低平均风险女性卵巢癌/输卵管癌/腹膜癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34251503e32a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406961, encodeId=f0f51406961bf, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=《2018 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南》解读, objectType=article, longId=139292, objectId=f7881392924f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7881392924f, replyNumber=0, likeNumber=27, createdTime=2018-05-29, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7881392924f, moduleTitle=《2018 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7881392924f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406960, encodeId=ce1914069609a, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2018.V2）, objectType=article, longId=132760, objectId=85da132e606b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85da132e606b, replyNumber=0, likeNumber=25, createdTime=2018-03-19, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85da132e606b, moduleTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2018.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85da132e606b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406959, encodeId=f9e11406959f9, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V5）, objectType=article, longId=131012, objectId=8377131012fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8377131012fe, replyNumber=0, likeNumber=24, createdTime=2018-03-02, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8377131012fe, moduleTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V5）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8377131012fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406958, encodeId=8bdf1406958fb, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V4）, objectType=article, longId=120056, objectId=c524120056aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c524120056aa, replyNumber=0, likeNumber=27, createdTime=2017-11-16, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c524120056aa, moduleTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c524120056aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406957, encodeId=6b47140695e76, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V3）, objectType=article, longId=113049, objectId=a21811304972, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a21811304972, replyNumber=0, likeNumber=33, createdTime=2017-09-18, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a21811304972, moduleTitle=NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a21811304972)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406956, encodeId=312d1406956d3, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=2015JSGO指南——卵巢癌（包括原发性腹膜癌和输卵管癌）的治疗发布, objectType=article, longId=79194, objectId=56b5e919417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56b5e919417, replyNumber=0, likeNumber=28, createdTime=2016-10-04, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56b5e919417, moduleTitle=2015JSGO指南——卵巢癌（包括原发性腹膜癌和输卵管癌）的治疗发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56b5e919417)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406955, encodeId=3bb1140695501, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=2016KSGO立场声明——腹膜，卵巢和输卵管癌的基因检测发布, objectType=article, longId=78108, objectId=b7e7e8108d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7e7e8108d5, replyNumber=0, likeNumber=35, createdTime=2016-09-23, rootId=0, userName=huperzia, userId=eae72584290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7e7e8108d5, moduleTitle=2016KSGO立场声明——腹膜，卵巢和输卵管癌的基因检测发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7e7e8108d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406954, encodeId=d171140695483, content=<a href='/topic/show?id=5bbf93e6942' target=_blank style='color:#2F92EE;'>#输卵管癌#</a>, objectTitle=2016NCCN临床实践指南——卵巢癌包括输卵管癌和原发性腹膜癌-证据块（2016.V1）发布, objectType=article, longId=76268, objectId=edf9e626858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edf9e626858, replyNumber=0, likeNumber=33, createdTime=2016-09-01, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edf9e626858, moduleTitle=2016NCCN临床实践指南——卵巢癌包括输卵管癌和原发性腹膜癌-证据块（2016.V1）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edf9e626858)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

输卵管癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#癌症# #卵巢癌# #输卵管癌# #原发性腹膜癌#

《2024 美国国立综合癌症网络卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南(第1版)》解读

2024-03-13发表于上海

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

Clin Cancer Res：Adavosertib联合各种化疗药治疗原发铂耐药的卵巢癌、输卵管癌、腹膜癌

2022-01-09

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

Clin Cancer Res：Adavosertib联合化疗治疗铂耐药的卵巢癌、输卵管癌及腹膜癌的效果

2021-12-05

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

原发性输卵管癌30例临床分析

2021-11-26

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

Gynecol Oncol：新诊断的卵巢癌、原发性腹膜癌和输卵管癌的静脉或腹膜内铂类化疗联合Veliparib和Bevacizumab的I期研究

2020-07-10

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究

2020-07-10

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

英国NICE批准将PARP抑制剂Lynparza，用于BRCA1或BRCA2突变的铂敏感型卵巢癌、输卵管癌或腹膜癌复发患者

2020-01-19

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

NICE批准PARP抑制剂Lynparza扩展用于晚期卵巢癌、输卵管癌和腹膜癌的维持治疗

2019-12-05

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2019.V2）

2019-09-27

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

输卵管癌超声误诊阔韧带肌瘤1例

2019-09-14

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2019.V1）

2019-03-28

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

2018 KSOG立场声明：双侧输卵管切除术降低平均风险女性卵巢癌/输卵管癌/腹膜癌风险

2018-10-06

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

《2018 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南》解读

2018-05-29

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2018.V2）

2018-03-19

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V5）

2018-03-02

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V4）

2017-11-16

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V3）

2017-09-18

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

2015JSGO指南——卵巢癌（包括原发性腹膜癌和输卵管癌）的治疗发布

2016-10-04

huperzia (审核中...)

前往app查看评论内容

#输卵管癌#

2016KSGO立场声明——腹膜，卵巢和输卵管癌的基因检测发布

2016-09-23

仁医06 (审核中...)

前往app查看评论内容

#输卵管癌#

2016NCCN临床实践指南——卵巢癌包括输卵管癌和原发性腹膜癌-证据块（2016.V1）发布

2016-09-01

科室
- - 订阅+
  - 更多科室
工具
服务